Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

HCWB - HCW Biologics Inc


Previous close
0.461
0   0%

Share volume: 5,507
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$0.46
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
9%
Profitability 0%
Dept financing 11%
Liquidity 47%
Performance 7%
Company vs Stock growth
vs
Performance
5 Days
-1.91%
1 Month
-25.66%
3 Months
-57.71%
6 Months
-67.99%
1 Year
-75.74%
2 Year
-81.99%
Key data
Stock price
$0.46
P/E Ratio 
-0.45
DAY RANGE
N/A - N/A
EPS 
-$1.04
52 WEEK RANGE
$0.40 - $2.18
52 WEEK CHANGE
-$0.74
MARKET CAP 
17.437 M
YIELD 
N/A
SHARES OUTSTANDING 
37.823 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$10,771
AVERAGE 30 VOLUME 
$10,210
Company detail
CEO:
Region: US
Website:
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

by leveraging our immunology expertise, hcw is developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell clearance.

Recent news